remove_red_eye 631 Views
#Business And Medicine #Gastroenterology #Pharmacist #Public Health
The US Food and Drug Administration (FDA) has approved the TransPyloric Shuttle (TPS) intragastric device to help eligible obese patients lose weight. The intragastric device is endoscopically implanted into the stomach to help patients feel full sooner and then endoscopically explanted after a year. It is made of silicone and is 85% to 90% smaller.